Cernilton in Patients with Inflammatory Chronic Prostatitis–Chronic Pelvic Pain Syndrome

Florian M.E. Wagenlehner, Henning Schneider, Martin Ludwig, Jörg Schnitker, Elmar Brähler, Wolfgang Weidner

A Pollen Extract (Cernilton) in Patients with Inflammatory Chronic Prostatitis–Chronic Pelvic Pain Syndrome: A Multicentre, Randomised, Prospective, Double-Blind, Placebo-Controlled Phase 3 Study.

Background: National Institutes of Health (NIH) category III prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent condition for which no standardised treatment exists.
Objectives: To assess the safety and efficacy of a standardised pollen extract in men with inflammatory CP/CPPS.